Literature DB >> 10931148

High levels of IL-10 and determination of other cytokines and chemokines in HIV-associated haemophagocytic syndrome.

O Benveniste1, N Dereuddre-Bosquet, P Clayette, C Leport, J L Vildé, D Dormont.   

Abstract

Haemophagocytic syndrome (HPS) and HIV infection are both associated with cytokine network dysregulation. We therefore analysed plasma levels and mRNA synthesis in peripheral blood mononuclear cells (PBMC) of cytokines, chemokines and chemokine receptors in one HIV-infected patient with HPS. We compared the results with those for eight HIV-infected patients with similar CD4+ T cell counts (207/mm3 versus controls: median 214/mm3) and plasma virus load (4.1 log copies/ml, versus controls: median 4.2 log copies/ml). The HPS patient had a lower viral DNA load in PBMC and higher plasma levels of interferon-gamma, IL-10, and macrophage inflammatory protein (MIP)-1beta. No difference in plasma tumour necrosis factor-alpha (TNF-alpha), IL-6 and MIP-1alpha concentration was observed between the HPS patient and control patients. No difference was observed in TNF-alpha, IL-1beta, IL-10, IL-4, MIP-1alpha, MIP-1beta, RANTES, CXCR-4, and CCR-5 mRNA levels in PBMC, but IL-6 levels were higher in the HPS patient. Our results emphasize the role of IL-10 in the control of immune hyperactivation that is observed in HPS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931148      PMCID: PMC1905689          DOI: 10.1046/j.1365-2249.2000.01288.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Cytokines in hemophagocytic syndrome.

Authors:  S Imashuku; S Hibi
Journal:  Br J Haematol       Date:  1991-03       Impact factor: 6.998

Review 2.  Techniques for quantification of cytokine mRNAs.

Authors:  O Benveniste; M Martin; F Villinger; D Dormont
Journal:  Cytokines Cell Mol Ther       Date:  1998-09

3.  Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity.

Authors:  S Ohga; A Matsuzaki; M Nishizaki; T Nagashima; T Kai; M Suda; K Ueda
Journal:  Am J Pediatr Hematol Oncol       Date:  1993-08

4.  Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.

Authors:  F Cocchi; A L DeVico; A Garzino-Demo; S K Arya; R C Gallo; P Lusso
Journal:  Science       Date:  1995-12-15       Impact factor: 47.728

5.  Interference of interleukin-10 with human immunodeficiency virus type 1 replication in primary monocyte-derived macrophages.

Authors:  N A Kootstra; A van 't Wout; H G Huisman; F Miedema; H Schuitemaker
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

6.  C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-gamma inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes.

Authors:  S J Roth; M W Carr; T A Springer
Journal:  Eur J Immunol       Date:  1995-12       Impact factor: 5.532

7.  Mechanisms for the inhibition of HIV replication by interferons-alpha, -beta, and -gamma in primary human macrophages.

Authors:  P R Meylan; J C Guatelli; J R Munis; D D Richman; R S Kornbluth
Journal:  Virology       Date:  1993-03       Impact factor: 3.616

8.  [Hemophagocytic syndrome in HIV infection].

Authors:  P Bourquelot; E Oksenhendler; M Wolff; S Fegueux; C Piketty; M F D'Agay; J P Clauvel
Journal:  Presse Med       Date:  1993-09-11       Impact factor: 1.228

9.  Epstein-Barr virus-associated hemophagocytic syndrome.

Authors:  H Kikuta
Journal:  Leuk Lymphoma       Date:  1995-02

Review 10.  Histiocytes and histiocytosis.

Authors:  M J Cline
Journal:  Blood       Date:  1994-11-01       Impact factor: 22.113

View more
  2 in total

1.  Characteristics of Activated Monocyte Phenotype Support R5-Tropic Human Immunodeficiency Virus.

Authors:  Sody M Munsaka; Melissa Agsalda; David Troelstrup; Ningjie Hu; Qigui Yu; Bruce Shiramizu
Journal:  Immunol Immunogenet Insights       Date:  2009

2.  The successful treatment of haemophagocytic syndrome in patients with human immunodeficiency virus-associated multi-centric Castleman's disease.

Authors:  J Stebbing; S Ngan; H Ibrahim; P Charles; M Nelson; P Kelleher; K N Naresh; M Bower
Journal:  Clin Exp Immunol       Date:  2008-12       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.